Long-term efficacy of biologic treatment for psoriasis after COVID-19 infection

Clin Exp Dermatol. 2022 Nov;47(11):2025-2026. doi: 10.1111/ced.15312. Epub 2022 Aug 9.

Authors

Katerina Bakirtzi¹, Ilias Papadimitriou¹, Efstratios Vakirlis¹, Themis Chatzi-Sotiriou², Dimitrios Ioannides¹, Eleni Sotiriou¹

Affiliations

¹ First Department of Dermatology and Venereology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Department of International and European Studies, School of Social Sciences, Humanities and Arts, University of Macedonia, Thessaloniki, Greece.

No abstract available

Publication types

Letter

MeSH terms

Biological Products* / therapeutic use
COVID-19*
Humans
Psoriasis* / complications
Psoriasis* / drug therapy
Severity of Illness Index

Substances

Biological Products